Key figures for this trade are also summarized in the multiples by trade table.
Independent pharmacy value at a glance
Estimate your pharmacy's value
Applies the cited SDE multiple band for your trade, then positions you inside it using recurring revenue, customer concentration, owner dependence, years operating and trend. Educational estimate, not an appraisal.
Educational estimate, not an appraisal or an offer. Ranges come from published closed-sale data and broker/adviser reports cited on each trade page; the adjustment weights are our own documented heuristic (see Editorial policy). Real estate, inventory and working capital are excluded.
Get the full valuation brief (printable)
Your inputs and range, the cited multiples behind it, the buyer type active at your size, three changes that move the multiple, and next steps - on this page, ready to print or save as a PDF.
Published pharmacy multiples by deal size
| Deal size / buyer | Multiple | Source |
|---|---|---|
| Main Street sales, 2021-2025 (sold) | 1.69x-3.75x SDE (median 2.45x); revenue 0.2x-0.45x | |
| All industries, Q2 2026 (context) | Under $500K deals: 2.0x SDE; $2M-$5M: 4.0x EBITDA; $5M-$50M: 5.8x EBITDA | IBBA / M&A Source / Pepperdine Market Pulse, Q2 2026 highlights |
What moves the multiple for a pharmacy
Key metric buyers ask for: Prescription count and trend, gross margin per script, payer/PBM mix, DIR fee exposure, front-store and specialty revenue, inventory.
Pushes you toward the top of the range
- Growing script count with healthy gross margin per script
- Niche revenue (compounding, long-term care, specialty, clinical services)
- Clean inventory and controlled-substance records
Pushes you toward the bottom
- PBM reimbursement pressure squeezing margin per script
- Dependence on one prescriber group or facility
- Controlled-substance recordkeeping problems found in diligence
How buyers value a pharmacy
Independent pharmacies sell on SDE or EBITDA to other pharmacists, regional chains and national chains (who sometimes buy only the prescription files). Inventory is usually counted separately at closing, so confirm what a quoted price includes.
Rule of thumb on revenue: About 0.2-0.45x revenue (BizBuySell sold middle half 0.20-0.45x). Use it only as a sanity check; buyers pay for cash flow they can finance.
Worked example: Main Street Apothecary (fictional)
Fictional business for illustration. Revenue $3,100,000, SDE $290,000. 190 scripts/day, 8% compounding revenue, $280K inventory at cost counted at close.
| Position in the cited range | Implied value | Multiple of revenue |
|---|---|---|
| At the low end (1.7x) | $493,000 | 0.16x |
| Midpoint (2.45x) | $710,000 | 0.23x |
| At the high end (3.75x) | $1,088,000 | 0.35x |
Who buys a pharmacy at each size
Pharmacists buying their first store; multi-store independents; regional chains; national chains buying files.
| SDE / EBITDA size | Most likely buyer | How they usually pay |
|---|---|---|
| Under ~$300K SDE | Pharmacist buyer | SBA or bank loan plus buyer cash; sometimes a seller note |
| ~$300K-$1M SDE | Multi-store independent | SBA loan, seller note, or cash from a larger buyer |
| $1M+ EBITDA | Regional or national chain | Mostly cash at close; rollover equity and earn-outs are common |
Thinking about selling your pharmacy?
See the step-by-step sale process, license transfer rules and documents buyers will ask for.
Frequently asked questions
How much is my pharmacy worth?
Pharmacies sold on BizBuySell from 2021-2025 went for a median 2.45x SDE (middle half 1.69-3.75x) and about 0.29x revenue. Script volume, margin per script and PBM exposure drive the multiple.
Does my DEA registration transfer?
Not automatically. 21 CFR 1301.52 bars transferring a DEA registration without DEA’s written consent, and controlled-substance inventory transfers follow DEA procedures. State boards also require a new permit on a change of ownership (Texas, for example, issues a new license number).
Is this an appraisal?
No. It is an educational estimate built from published data. Lenders, courts and the IRS may require a credentialed appraisal; see appraisal vs estimate.
Sources
- BizBuySell Valuation Benchmarks - Pharmacy (accessed 2026-09-23)
- BizBuySell - Business valuation multiples by industry (sold Q3 2021-Q2 2026) (accessed 2026-09-23)